Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 1 040 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,325100%1,488100% +12.32%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States1,19390%1,35591.1% +13.58%
Europe103.617.8%106.157.1% +2.44%
Other28.312.1%26.911.8% -4.96%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA522012Chairman & Chief Executive Officer
Russell J. Cox542012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA482013Chief Financial Officer & Executive Vice President
Karen L. Smith MD, PhD492015Chief Medical Officer, Global Head-R&D
Paul L. Berns502010Independent Class II Director
Patrick G. Enright, MBA552012Independent Director
Seamus C. Mulligan562012Independent Director
Ken W. O'Keefe, MBA502012Independent Director
Rick E. Winningham, MBA572012Lead Independent Director
Catherine Angell Sohn, PhD632012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 59,742,232 58,344,266 97.7% 0 0.0% 97.7%
Shareholders
NameEquities%
Putnam Investment Management LLC 7,668,086 12.8%
Fidelity Management & Research Co. 7,389,585 12.3%
The Vanguard Group, Inc. 4,371,250 7.30%
BlackRock Fund Advisors 2,217,300 3.70%
Renaissance Technologies LLC 1,560,300 2.61%
Cadian Capital Management LP 1,540,782 2.57%
Westfield Capital Management Co. LP 1,259,389 2.10%
FIL Investment Advisors (UK) Ltd. 1,224,757 2.04%
Seamus C. Mulligan 1,048,008 1.75%
Janus Capital Management LLC 999,112 1.67%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals
Advertisement
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalization (M$)
JAZZ PHARMACEUTICALS P..33.95%8 725
ABBVIE INC5.03%104 810
MERCK KGAA4.69%14 491
KYOWA HAKKO KIRIN CO L..10.01%9 226
CONVATEC GROUP PLC14.96%6 632
MALLINCKRODT PLC-8.53%4 771
ZHANGZHOU PIENTZEHUANG..8.71%4 377
BETTA PHARMACEUTICALS ..--.--%3 974
INDIVIOR PLC8.71%2 890
YUHAN CORP--.--%2 363
ADVANCED ACCELERATOR A..--.--%1 729
MAYNE PHARMA GROUP LTD3.35%1 648
SUPERNUS PHARMACEUTICA..21.78%1 542
THERAPEUTICSMD INC21.14%1 420
EAGLE PHARMACEUTICALS ..4.60%1 264
REPLIGEN CORPORATION13.89%1 188
AIMMUNE THERAPEUTICS I..9.10%1 121
KNIGHT THERAPEUTICS IN..-3.74%1 101
FUJIAN COSUNTER PHARMA..--.--%1 033
NICHI-IKO PHARMACEUTIC..3.59%945
AB SCIENCE20.91%704
Sector Specialty & Advanced Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Vascular Cures
Beecken Petty O'Keefe & Co. LP
CHD Bioscience, Inc.
Adapt Pharma Ltd.
Ariel Pharmaceuticals, Inc.
Longitude Capital Management Co. LLC
World Affairs Council of Philadelphia
Circ Pharma Ltd.
Jazz Pharmaceuticals, Inc.
Pharmaceutical Research & Manufacturers of America
SutroVax, Inc.
Sohn Health Strategies LLC
Orbus Therapeutics, Inc.
Nueva School
Aptinyx, Inc.
InfaCare Pharmaceutical Corp.
Raven Biotechnologies, Inc.
University of the Sciences in Philadelphia
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2017 People , Fundamentals and Ownership